Literature DB >> 19440814

Lack of association between tyrosine kinase 2 (TYK2) gene polymorphisms and susceptibility to SLE in a Japanese population.

Chieko Kyogoku1, Akio Morinobu, Kunihiro Nishimura, Daisuke Sugiyama, Hiroshi Hashimoto, Yoshiaki Tokano, Tsuneyo Mimori, Chikashi Terao, Fumihiko Matsuda, Takayoshi Kuno, Shunichi Kumagai.   

Abstract

Tyrosine kinase 2 (TYK2) is a type I interferon (IFN) signaling pathway gene and was previously reported to be a risk factor for systemic lupus erythematosus (SLE) in Caucasian populations. In order to test for its genetic association with SLE in a Japanese population, TYK2 single nucleotide polymorphisms (SNPs), rs2304256, rs12720270 and rs280519, were genotyped. A case-control association study was performed in a total of 411 Japanese SLE patients and 467 healthy controls. Linkage disequilibrium (LD) among TYK2 SNPs was examined. According to the data from 94 healthy controls, non-synonymous rs2304256 resulting in Val --> Phe substitution was revealed to be in a LD with rs12720270 and rs280519. Therefore, we further genotyped rs2304256 as a tag SNP in the full sample sets. As a result, no differences in genotype distribution and allelic frequencies of rs2304256 were found between SLE patients and healthy controls. In conclusion, TYK2 is not a genetic risk factor for SLE in a Japanese population. Our result suggests that there is an ethnic difference in the susceptibility genes for SLE.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19440814     DOI: 10.1007/s10165-009-0173-1

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  10 in total

1.  Meta-analysis of TYK2 gene polymorphisms association with susceptibility to autoimmune and inflammatory diseases.

Authors:  Jin-Hui Tao; Yan-Feng Zou; Xiao-Liang Feng; Jing Li; Fang Wang; Fan-Ming Pan; Dong-Qing Ye
Journal:  Mol Biol Rep       Date:  2010-12-08       Impact factor: 2.316

2.  Associations between PXK and TYK2 polymorphisms and systemic lupus erythematosus: a meta-analysis.

Authors:  Young Ho Lee; Sung Jae Choi; Jong Dae Ji; Gwan Gyu Song
Journal:  Inflamm Res       Date:  2012-05-17       Impact factor: 4.575

3.  Genetic association and interaction between the IRF5 and TYK2 genes and systemic lupus erythematosus in the Han Chinese population.

Authors:  Liang Tang; Pengcheng Wan; Yong Wang; Jiabao Pan; Yan Wang; Bifeng Chen
Journal:  Inflamm Res       Date:  2015-08-21       Impact factor: 4.575

Review 4.  The role of tyrosine kinases in systemic lupus erythematosus and their potential as therapeutic targets.

Authors:  Wen-Hai Shao; Philip L Cohen
Journal:  Expert Rev Clin Immunol       Date:  2014-03-29       Impact factor: 4.473

5.  Identification of 38 novel loci for systemic lupus erythematosus and genetic heterogeneity between ancestral groups.

Authors:  Yong-Fei Wang; Yan Zhang; Zhiming Lin; Huoru Zhang; Ting-You Wang; Yujie Cao; David L Morris; Yujun Sheng; Xianyong Yin; Shi-Long Zhong; Xiaoqiong Gu; Yao Lei; Jing He; Qi Wu; Jiangshan Jane Shen; Jing Yang; Tai-Hing Lam; Jia-Huang Lin; Zhi-Ming Mai; Mengbiao Guo; Yuanjia Tang; Yanhui Chen; Qin Song; Bo Ban; Chi Chiu Mok; Yong Cui; Liangjing Lu; Nan Shen; Pak C Sham; Chak Sing Lau; David K Smith; Timothy J Vyse; Xuejun Zhang; Yu Lung Lau; Wanling Yang
Journal:  Nat Commun       Date:  2021-02-03       Impact factor: 14.919

Review 6.  Immunogenicity and other problems associated with the use of biopharmaceuticals.

Authors:  Michael G Tovey; Christophe Lallemand
Journal:  Ther Adv Drug Saf       Date:  2011-06

7.  Systemic Lupus Erythematosus: Old and New Susceptibility Genes versus Clinical Manifestations.

Authors:  De Azevêdo Silva J; Addobbati C; Sandrin-Garcia P; Crovella S
Journal:  Curr Genomics       Date:  2014-02       Impact factor: 2.236

8.  Polymorphisms in IRF5 and TYK2 Genes Are Associated with Rheumatoid Arthritis in a Chinese Han Population.

Authors:  Yuqin Peng; Bingqian Chen; Xiaowen Sheng; Yufeng Qian
Journal:  Med Sci Monit       Date:  2021-02-15

Review 9.  Safety, Tolerability, and Immunogenicity of Interferons.

Authors:  Michael G Tovey; Christophe Lallemand
Journal:  Pharmaceuticals (Basel)       Date:  2010-04-20

10.  Two common disease-associated TYK2 variants impact exon splicing and TYK2 dosage.

Authors:  Zhi Li; Maxime Rotival; Etienne Patin; Frédérique Michel; Sandra Pellegrini
Journal:  PLoS One       Date:  2020-01-21       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.